We have initiated a follow-up study that would compare 6 and 12 months virologic response in HIV-infected versus TB/HIV-coinfected children on efavirenz-based therapy, while accounting for other factors such as medication adherence, CYP2B6 516G→T genotype and efavirenz middose concentrations. Here, CYP2B6 is linked to tuberculosis.